| 書目名稱 | Hormone Therapy in Breast and Prostate Cancer | | 編輯 | V. Craig Jordan,Barrington J.A. Furr | | 視頻video | http://file.papertrans.cn/429/428320/428320.mp4 | | 概述 | Includes supplementary material: | | 叢書名稱 | Cancer Drug Discovery and Development | | 圖書封面 |  | | 描述 | Millions of people are now successfully using hormone antagonists for the treatment of endocrine-dependent cancers. In Hormone Therapy in Breast and Prostate Cancer, many of today‘s leading researchers and clinicians describe the principles underlying these targeted treatments, assess the actions of new and established agents, and illustrate the new applications of hormonal chemoprevention for breast cancer. Topics range from preclinical and clinical antiestrogens to the inhibition of estrogen synthesis and the effects of androgen withdrawal. A wide variety of proven and new agents are discussed-antiestrogens, including aromatase inhibitors (anastrozole, letrozole, and others), SERMs (tamoxifen, raloxifene, and others), and such antiandrogenic strategies as goserelin and bicalutamide. .Unique in its synthesis, Hormone Therapy in Breast and Prostate Cancer offers medical and surgical oncologists, urologists, physicians, and clinical pharmacologists a sound basis for understanding targeted treatments of breast and prostate cancers, and provides a well-proven model for developing powerful new cancer therapeutics. | | 出版日期 | Book 2002 | | 關(guān)鍵詞 | Drogen; cancer; cancer prevention; cancer research; carcinogenesis; cell; drug; drug resistance; hormones; li | | 版次 | 1 | | doi | https://doi.org/10.1007/978-1-59259-152-7 | | isbn_softcover | 978-1-60761-471-5 | | isbn_ebook | 978-1-59259-152-7Series ISSN 2196-9906 Series E-ISSN 2196-9914 | | issn_series | 2196-9906 | | copyright | Springer Science+Business Media New York 2002 |
The information of publication is updating
|
|
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-6 16:25
發(fā)表于 2025-3-21 19:10:27
